Scarring Alopecia (Cicatricial Alopecia) is a rare condition where inflammation destroys hair follicles, replacing them with scar tissue. A hair transplant consultation assesses the extent of scarring and evaluates whether transplantation is feasible.

Scarring alopecia — also called cicatricial alopecia — involves permanent destruction of hair follicles replaced by fibrotic scar tissue, which is fundamentally different from non-scarring conditions like androgenetic alopecia. At Claire Derma, the transplant consultation for scarring alopecia carries additional complexity because the scarred recipient tissue has compromised blood supply and may not support graft survival at the same rate as healthy scalp.

This treatment targets acne and skin congestion by:

Thorough scalp examination to identify scarred and healthy areas.

Assessment of inflammation activity and scalp condition.

Review of medical history and possible underlying causes.

Development of a tailored approach for hair restoration.

Lichen Planopilaris – This lymphocytic scarring alopecia destroys follicles through perifollicular inflammation visible on biopsy. At Claire Derma, we require at least eighteen months of documented clinical and dermoscopic inactivity before considering transplantation.

Frontal Fibrosing Alopecia – Progressive hairline recession with eyebrow loss poses unique transplant challenges because the disease margin may still be slowly advancing.

Traumatic and Burn Scars – Scars from burns, surgery, or accidents have the most predictable transplant outcomes because there is no ongoing disease process that could destroy new grafts.

The type of scarring alopecia significantly influences transplant planning at Claire Derma. Each condition creates a different pattern of follicle destruction and leaves behind scar tissue with varying characteristics that affect graft survival rates. Burn scars and traumatic scars typically have a well-defined stable border and respond reasonably well to transplantation.

Evaluates whether the scalp is stable enough for transplantation.

Determines the number and location of viable donor follicles.

Assesses risk factors to prevent poor graft survival.

Provides personalized recommendations on timing and technique.

Vascularity Assessment – Our trichologists evaluate blood flow in the scarred area using clinical assessment and dermoscopy before committing to transplantation.

Test Graft Session – For extensive or dense scars with uncertain graft survival potential, Claire Derma may recommend a small test session of 50 to 100 grafts placed into the scarred area.

Staged Density Building – Rather than attempting maximum density in a single session, our team builds coverage in stages. The first procedure establishes baseline vascularity through graft survival, and subsequent sessions — typically six.

Recipient site preparation in scarring alopecia is more demanding than in standard androgenetic transplant cases. Scar tissue is denser, less vascular, and more resistant to graft insertion than normal scalp skin.

Detailed assessment by qualified trichologists.

Identification of stable, viable areas for transplantation.

Avoids unnecessary treatments on active scar tissue.

Customized, safe hair restoration plan.

Expert advice on long-term management of scarring alopecia.

Benefit – Thorough disease activity confirmation prevents premature transplantation into potentially active scarring alopecia. At Claire Derma, the eighteen-month inactivity requirement and dermoscopic monitoring protect your donor supply from being wasted on.

Benefit – Staged surgical planning maximises graft survival in compromised tissue. By building density gradually across multiple sessions, our approach achieves better overall outcomes than attempting a single large procedure in scar.

Benefit – Integrated disease management alongside surgical planning. Our trichologists continue monitoring your scarring alopecia and managing any maintenance medication even after transplantation.

The consultation for scarring alopecia transplantation at Claire Derma provides honest, detailed guidance that prevents patients from pursuing surgery with unrealistic expectations. Scarring alopecia transplants achieve lower density than standard androgenetic procedures, and patients need to understand that the goal is cosmetically meaningful improvement rather than full restoration.

This treatment is ideal for individuals who:

Patients with stable, non-progressive scarring alopecia.

Individuals whose scarred scalp is healthy enough to support grafts.

Patients seeking expert evaluation before undergoing hair transplant.

After the consultation at Claire Derma, patients with scarring alopecia receive a detailed written assessment that includes the diagnosis, disease activity status, recipient bed vascularity evaluation, estimated graft count, recommended staging plan, and a realistic projection of achievable density. If the disease is not yet confirmed quiescent, we outline the monitoring schedule and the criteria that must be met before transplant clearance is granted.